Primary Sjogren's Disease trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All Primary Sjogren's Disease trials nationally

Cities in Illinois

Recruiting trials in Illinois

• Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
  NCT07404865 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago, Schaumburg, Willowbrook